Dr Amol Akhade (@SuyogCancer) / X

Dr Amol Akhade

9,937 posts

Dr Amol Akhade

@SuyogCancer

Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists

Mumbai

suyogcancerclincs.com

Joined June 2019

Pinned
Dr Amol Akhade
@SuyogCancer
Feb 1, 2022
Happy to share our article in lancet oncology about Accelerated pathway ( mis ) use in oncology drug approval and differential treatment given by pharma giants to LMIC , while withdrawing cancer drugs. Thank you @oncology_bg @SirohiBhawna for being with me for this efforts .
Dr Amol Akhade
@SuyogCancer
Dec 16, 2024
The amount of cancer patients seen by me in opd today at government hospital in Mumbai India 🇮🇳. 140 pts . I am doing this for free of cost ,( I don't take any honorarium for this ) , twice a week , for last 11 years (since March 2013 ) All get free cancer treatment
Dr Amol Akhade
@SuyogCancer
Aug 27, 2021
Replying to @business
Natural infection induced immunity is bound to be better than the vaccine . So those who have recovered from covid , may be they can skip the vaccine? Especially in countries where there is vaccine shortage ?
Dr Amol Akhade
@SuyogCancer
Oct 21, 2022
Pts seen by me in oncology opd alone today in government Hospital Around 90 pts. These are extremely poor pts who don't afford simple cytotoxic chemotherapy also. When we talk about LMICs and cancer policy for LMICs , we have to remember this. THIS IS LMIC.
Dr Amol Akhade
@SuyogCancer
Jun 3, 2025
Excellent summary slides for current evidence for pancreatic cancer treatment . Useful for quick reference. @ASCO #asco25 taken from talk by Dr Brian Wolpin 👍@OncoAlert @brunolarvol
Dr Amol Akhade
@SuyogCancer
Jun 1, 2025
What if this was a drug ?🙂 🆕 NEJM | June 2025 🎯 CHALLENGE Trial: Structured exercise after adjuvant chemo in colon cancer 📦 RCT | n=889 | Median FU: 7.9 yrs 🟠 3-yr structured aerobic program vs health ed alone 📈 Primary Endpoint: Disease-Free Survival (DFS) 🔹 HR 0.72
Dr Amol Akhade
@SuyogCancer
May 19, 2025
Top 10 GI Trials – ASCO 2025 The biggest GI breakthroughs you must track this year! 🧬 ATOMIC – Atezolizumab + FOLFOX in stage III MSI-H colon 🛡️ MATTERHORN – Durvalumab + FLOT in gastric/GEJ 🧪 DYNAMIC-III – ctDNA-guided chemo in colon 💉 DESTINY-Gastric04 – T-DXd vs RAM+PTX
Dr Amol Akhade
@SuyogCancer
Nov 25, 2023
I don't know who needs to know this more ( oncologist or patients or both ) But this is one of the best piece about cancer and diet misinformation in @TheLancetOncol. Say NO to ketogenic diets , alkaline diets as treatment options. Say NO to Quackery .
Dr Amol Akhade
@SuyogCancer
Jun 2, 2024
How to treat advanced NSCLC with driver mutation in 2024 ? @ASCO #ASCO24
Dr Amol Akhade
@SuyogCancer
Jun 6, 2025
Another money 💰 slide from #asco25 @ASCO . Treatment algorithm for HR +/ HER 2 -ve mBC @OncoAlert @medicalwatchBC
Dr Amol Akhade
@SuyogCancer
Nov 23, 2024
Much needed statement issued by @TataMemorial . This should clear any misconception that cancer patients or caregivers may have after recent viral video about use of diet and other methods to achieve so called " CURE " for the advanced cancer . Let's avoid such
Dr Amol Akhade
@SuyogCancer
Jun 8, 2025
How to select pts with HCC for various local therapies? RFA ,MWA , TACE , SIRT , SBRT . Useful for clinical decision-making. Taken from #asco25 @ASCO Do u agree ? @dr_yakupergun @NiuSanford @jryckman3 @OncoAlert @medicalwatchBC
Dr Amol Akhade
@SuyogCancer
May 18, 2025
Top 10 Breast Cancer Trials to Watch at #ASCO25 Save the date ⏰ Big data in HER2+, TNBC & HR+ mBC! 1️⃣ DESTINY-Breast09 – T-DXd+P vs THP (1L HER2+ MBC) [LBA] 2️⃣ ASCENT-04 – SG+pembro vs chemo+pembro (1L TNBC) [LBA] 3️⃣ SERENA-6 – Camizestrant+CDK4/6i in ESR1mut HR+ ABC [LBA] 4️⃣
Dr Amol Akhade
@SuyogCancer
Dec 16, 2024
Replying to @108_sacred
Team of 3 junior doctors ( non oncologist ) keep investigations and reports ready to help me in this . It is team work .